C12N 1 - Micro-organisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving micro-organisms or compositions thereof; Processes of preparing or isolating a composition containing a micro-organism; Culture media therefor

Patents for C12N 1 - Micro-organisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving micro-organisms or compositions thereof; Processes of preparing or isolating a composition containing a micro-organism; Culture media therefor (148,866)
12/2002
12/10/2002	US6492509 Fatty acyl-CoA: fatty alcohol acyltransferases
12/10/2002	US6492508 Nucleic acids encoding extracellular matrix proteins
12/10/2002	US6492507 Polynucleotides encoding human eosinophil-derived basic protein
12/10/2002	US6492499 Human pancreatitis-associated protein
12/10/2002	US6492495 PTP-S31: a novel protein tyrosine phosphatase
12/10/2002	US6492493 Bone morphogenetic protein (BMP)-17 and BMP-18 compositions
12/10/2002	US6492331 NL8 tie ligands homologues
12/10/2002	US6492167 Membrane protein for use in the treatnment of diabetes, hypotension, endocrine defects
12/10/2002	US6492164 Circular DNA expression cassettes for gene transfer
12/10/2002	US6492161 Bacteriophage RM 378 of a thermophilic host organism
12/10/2002	US6492159 Cloudy fruit juices and methods for making same
12/10/2002	US6492158 The invention provides isolated nucleic acid and amino acid sequences of hskif6, antibodies to hskif6, methods of screening for hskif6 modulators using biologically active hskif6, and kits for screening for hskif6 modulators.
12/10/2002	US6492157 Methods are provided for the treatment of conditions associated with cells proliferation, cells differentiation and cell survival. in particular, the dual-specificity phosphatase dsp-9, and polypeptide variants thereof that
12/10/2002	US6492153 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof
12/10/2002	US6492152 Nucleic acids encoding the core 1 .beta.3-galactosyl transferases are described. the enzymes and the nucleic acids encoding said enzymes have been identified in human, rat, mouse d. melanogaster and c. elegans. the polypeptides exhibit
12/10/2002	US6492151 The invention provides isolated nucleic acid and amino acid sequences of hskip3d, antibodies to hskip3d, methods of screening for hskip3d modulators using biologically active hskip3d, and kits for screening for hskip3d modulators.
12/10/2002	US6492146 Process for the preparation of phosphatidylserines
12/10/2002	US6492138 Polynucleotides encoding a novel SHC-binding protein
12/10/2002	US6492126 Compositions and methods for the treatment and diagnosis of cardiovascular disease
12/10/2002	US6492108 Polynucleotides that encode human delta-6 desaturase homolog (d6dh); use for treating cardiovascular diseases, disorders of aging, disorders of fatty acid metabolism, and cancer
12/10/2002	US6491924 Sequence of at least 5 consecutive amino acids in the polypeptide of seq id no: 1
12/10/2002	US6491907 Genetic engineered chimera particles comprising capsids from adeno-associated virus and genome inverted terminal repeat sequences as vectors for supplying and expressing nucleotide sequence in cells
12/10/2002	US6491243 Continuous process for irradiating of polytetrafluoroethylene (PTFE)
12/10/2002	US6490824 Method for culturing a basidiomycetous fungus in a liquid culture medium
12/10/2002	CA2196085C Mhc complexes and uses thereof
12/10/2002	CA2088574C Process for producing enzymes having superoxide dismutase activity, novel superoxide dismutase enzymes and novel pharmaceutical compositions comprising enzymes having superoxide dismutase activity
12/05/2002	WO2002097395A2 P-cadherin as a target for anti-cancer therapy
12/05/2002	WO2002097120A1 Attractin/mahogany-like polypeptides, polynucleotides, antibodies and methods of use thereof
12/05/2002	WO2002097110A2 TUMOR ENDOTHELIAL MARKER 7α MOLECULES AND USES THEREOF
12/05/2002	WO2002097096A2 Nucleotide sequences which code for the metd gene
12/05/2002	WO2002097089A1 Microorganisms useful in industrial production
12/05/2002	WO2002097086A1 Industrially useful microorganisms
12/05/2002	WO2002097081A2 Method to generate non virulent microorganisms from pathogenic ones trough permanent genetic modification of their biological membrane for vaccine production
12/05/2002	WO2002097079A2 Gene encoding molecular motor protein and diagnosis method for the disease related to the gene
12/05/2002	WO2002097075A2 Capping enzyme of flavivirus and utilization of this protein in a process to test drugs with antiviral properties
12/05/2002	WO2002097064A1 Host microorganisms
12/05/2002	WO2002097063A1 Production of bioavailable folic acid
12/05/2002	WO2002097062A2 Recombinant narbonolide polyketide synthase
12/05/2002	WO2002097060A2 Carbohydrate-associated proteins
12/05/2002	WO2002097050A2 Novel estrogen receptor ligand binding domain variants and novel ligands and pharmaceutical compositions
12/05/2002	WO2002097046A2 B7 related protein-2 molecules and uses thereof
12/05/2002	WO2002097043A2 Wnv core protein/capsid interacting protein and uses of the same
12/05/2002	WO2002097035A2 Secreted proteins
12/05/2002	WO2002097033A2 Antibodies that immunospecifically bind to trail receptors
12/05/2002	WO2002097032A2 Proteins associated with cell growth, differentiation, and death
12/05/2002	WO2002096952A2 Conjugate of a transport protein and a protein for modulation of notch signalling
12/05/2002	WO2002096951A1 Molecules for disease detection and treatment
12/05/2002	WO2002096942A2 Recombinant dna encoding the major allergen of plantago lanceolata pollen pla l 1, and applications thereof
12/05/2002	WO2002096932A1 Transporters and ion channels
12/05/2002	WO2002072854A3 Process for the preparation of d-pantothenic acid and/or salts thereof
12/05/2002	WO2002070557A3 Nuclear hormone receptor ligand binding domain
12/05/2002	WO2002068470A3 Interferon-alpha induced gene
12/05/2002	WO2002053758A3 Method for producing heterologous proteins in a homothallic fungus of the sordariaceae family
12/05/2002	WO2002051866A3 Antibacterial treatments
12/05/2002	WO2002038732A3 Human testis specific serine/threonine kinase
12/05/2002	WO2002028902A3 Nectin polypeptides, polynucleotides, methods of making and use thereof
12/05/2002	WO2002028351A9 Recombinant mucin binding proteins from steptococcus pneumoniae
12/05/2002	WO2002024716A3 Nucleotide sequences which code for the tmk gene
12/05/2002	WO2002020766A3 G-csf analog compositions and methods
12/05/2002	WO2002016413A3 Cripto tumour polypeptide
12/05/2002	WO2002012468A3 2,5-dkg permeases
12/05/2002	WO2002006453A3 Regulation of human desc1-like serine protease
12/05/2002	WO2002000715A3 Mammal 2p domain mechano-sensitive k+ channel, cloning and applications thereof
12/05/2002	WO2001092491A3 Mammalian protein phosphatases identified by in-silico analysis
12/05/2002	WO2001085948A3 Nucleotide sequences which code for the coryneform acyl carrier protein gene
12/05/2002	WO2001085947A3 Compounds and methods for the diagnosis and treatment of babesia microti infection
12/05/2002	WO2001079448A3 Trp8, a transient receptor potential channel expressed in taste receptor cells
12/05/2002	WO2001044816A9 Conformational and topological protein regulation
12/05/2002	WO2001032926A3 Differentially expressed genes involved in angiogenesis, the polypeptides encoded thereby, and methods of using the same
12/05/2002	WO2001032685A9 Gene expression directed by a super-psa promoter
12/05/2002	WO2001023589A9 23431, a novel human ubiquitin protease
12/05/2002	WO2001021796A9 Gl50 molecules and uses therefor
12/05/2002	WO2001021772A9 Methods and microorganisms for production of panto-compounds
12/05/2002	US20020184661 Dna shuffling to produce nucleic acids for mycotoxin detoxification
12/05/2002	US20020184658 Aromatic amino acid biosynthetic enzymes
12/05/2002	US20020183508 Sequences of hepatitis C virus genotypes and their use as prophylactic, therapeutic and diagnostic agents
12/05/2002	US20020183505 Secreted and transmembrane polypeptides and nucleic acids encoding the same
12/05/2002	US20020183503 Nucleotide sequences coding polypeptide for use in the treatment and diagnosis of immunological, infectious, inflammatory and cancer disorders
12/05/2002	US20020183500 Nucleotide sequence coding polypeptide for use in the treatment, diagnosis, classification and imaging of lung cancer
12/05/2002	US20020183494 Secreted and transmembrane polypeptides and nucleic acids encoding the same
12/05/2002	US20020183493 Secreted and transmembrane polypeptides and nucleic acids encoding the same
12/05/2002	US20020183269 Novel compounds
12/05/2002	US20020183267 For use as antibiotics; for therapy of Staphylococcus aureas infection
12/05/2002	US20020183250 For use in therapy of sleep disorders
12/05/2002	US20020183185 Method for the concentration of fluid-borne pathogens
12/05/2002	US20020182734 Transformation of preferential microorganism; obtain microorganism, incubate with preferential nucleotide sequences, transform microorganism, detect insertion of nucleotide sequences into chromosome
12/05/2002	US20020182709 Functional gene array in yeast
12/05/2002	US20020182707 Modified microbes
12/05/2002	US20020182706 Purification of viral envelope proteins; obtain cell, transfect with genetically engineered virus, lyse cell, recover envelope proteins
12/05/2002	US20020182704 Plant proteinases
12/05/2002	US20020182703 Human defensin polypeptide Def-X, genomic DNA and cDNA, composition containing them and applications to diagnosis and to therapeutic treatment
12/05/2002	US20020182699 Nucleotide sequences coding enzymatic polypeptide for use in detergents
12/05/2002	US20020182697 Synthetic enzymes for the production of coniferyl alcohol, coniferylaldehyde, ferulic acid, vanillin and vanillic acid and their use
12/05/2002	US20020182693 Polypeptide having larvae growth inhibiting or insecticidal effect on scarabaeidae insects and polynucleotide encoding the same
12/05/2002	US20020182691 Nucleotide sequences coding transport protein for use in nervous system disorders
12/05/2002	US20020182689 Nucleotide sequences coding enzymatic polypeptide for use genration of amino acids
12/05/2002	US20020182688 Method for producing L-glutamic acid
12/05/2002	US20020182686 Generating prevential nucleotide sequences; obtain nucleotide sequences, incubate with primers, expose to polymerase, recover nucleotide sequences
12/05/2002	US20020182683 Vascular endothelial growth factor 2
12/05/2002	US20020182681 Peptide for use in treatment of cancer, parkinson's and metabolic disorders

1 ... 974 975 976 977 978 979 980 981 982 983 984 985 986 987 988 989 990 991 992 993 994 ... 1489